Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Alzheimer's Disease

  Free Subscription


06.11.2017

1 Alzheimers Dement
1 BMC Neurosci
3 Brain
3 Brain Res
2 Curr Alzheimer Res
1 Curr Opin Neurol
1 Exp Gerontol
1 Int J Neurosci
3 J Alzheimers Dis
2 J Neurosci
2 Lancet Neurol
6 Neurology
1 PLoS Genet
3 PLoS One
2 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Alzheimers Dement

  1. MONTAL V, Vilaplana E, Alcolea D, Pegueroles J, et al
    Cortical microstructural changes along the Alzheimer's disease continuum.
    Alzheimers Dement. 2017 Oct 31. pii: S1552-5260(17)33767.
    PubMed     Text format     Abstract available


    BMC Neurosci

  2. KUMAR S, Chowdhury S, Kumar S
    In silico repurposing of antipsychotic drugs for Alzheimer's disease.
    BMC Neurosci. 2017;18:76.
    PubMed     Text format     Abstract available


    Brain

  3. GRINBERG LT, Heinsen H
    Light at the beginning of the tunnel? Investigating early mechanistic changes in Alzheimer's disease.
    Brain. 2017;140:2770-2773.
    PubMed     Text format    

  4. DU F, Yu Q, Yan S, Hu G, et al
    PINK1 signalling rescues amyloid pathology and mitochondrial dysfunction in Alzheimer's disease.
    Brain. 2017 Oct 25. doi: 10.1093.
    PubMed     Text format     Abstract available

  5. TOSUN D, Landau S, Aisen PS, Petersen RC, et al
    Association between tau deposition and antecedent amyloid-beta accumulation rates in normal and early symptomatic individuals.
    Brain. 2017;140:1499-1512.
    PubMed     Text format     Abstract available


    Brain Res

  6. ZHAO Q, Lu H, Metmer H, Li WXY, et al
    Evaluating Functional Connectivity of Executive Control Network and Frontoparietal Network in Alzheimer's Disease.
    Brain Res. 2017 Oct 24. pii: S0006-8993(17)30483.
    PubMed     Text format     Abstract available

  7. LIU M, Jevtic S, Markham-Coultes K, Ellens NPK, et al
    Investigating the efficacy of a combination Abeta-targeted treatment in a mouse model of Alzheimer's disease.
    Brain Res. 2017 Oct 21. pii: S0006-8993(17)30473.
    PubMed     Text format     Abstract available

  8. CHIARAVALLOTI A, Barbagallo G, Ricci M, Martorana A, et al
    Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer's disease patients: a CSF and FDG PET study.
    Brain Res. 2017 Oct 21. pii: S0006-8993(17)30474.
    PubMed     Text format     Abstract available


    Curr Alzheimer Res

  9. RUGGIERO G, Iavarone A, Iachini T
    Allocentric to Egocentric Spatial Switching: Impairment in aMCI and Alzheimer's Disease Patients?
    Curr Alzheimer Res. 2017 Oct 30. doi: 10.2174/1567205014666171030114821.
    PubMed     Text format     Abstract available

  10. XAVIER C, Justine B, Laurent O, Isabelle L, et al
    Body-centred and object-centred motor imagery in Alzheimer disease.
    Curr Alzheimer Res. 2017 Oct 29. doi: 10.2174/1567205014666171030105720.
    PubMed     Text format     Abstract available


    Curr Opin Neurol

  11. ITURRIA-MEDINA Y, Hachinski V, Evans AC
    The vascular facet of late-onset Alzheimer's disease: an essential factor in a complex multifactorial disorder.
    Curr Opin Neurol. 2017;30:623-629.
    PubMed     Text format     Abstract available


    Exp Gerontol

  12. LI J, Cui X, Ma X, Wang Z, et al
    rBTI reduced beta-amyloid-induced toxicity by promoting autophagy-lysosomal degradation via DAF-16 in Caenorhabditis elegans.
    Exp Gerontol. 2017;89:78-86.
    PubMed     Text format     Abstract available


    Int J Neurosci

  13. YUAN H, Du L, Ge P, Wang X, et al
    Association of Microtubule-Associated Protein Tau Gene Polymorphisms with the Risk of Sporadic Alzheimer's Disease: A Meta-Analysis.
    Int J Neurosci. 2017 Nov 3:1-22. doi: 10.1080/00207454.2017.1400972.
    PubMed     Text format     Abstract available


    J Alzheimers Dis

  14. DEVANAND DP, Lentz C, Chunga RE, Ciarleglio A, et al
    Change in Odor Identification Impairment is Associated with Improvement with Cholinesterase Inhibitor Treatment in Mild Cognitive Impairment.
    J Alzheimers Dis. 2017 Oct 21. doi: 10.3233/JAD-170497.
    PubMed     Text format     Abstract available

  15. HANDELS RLH, Wimo A, Dodel R, Kramberger MG, et al
    Cost-Utility of Using Alzheimer's Disease Biomarkers in Cerebrospinal Fluid to Predict Progression from Mild Cognitive Impairment to Dementia.
    J Alzheimers Dis. 2017 Oct 21. doi: 10.3233/JAD-170324.
    PubMed     Text format     Abstract available

  16. VAN DUIJN S, Bulk M, van Duinen SG, Nabuurs RJA, et al
    Cortical Iron Reflects Severity of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Oct 21. doi: 10.3233/JAD-161143.
    PubMed     Text format     Abstract available


    J Neurosci

  17. NAKAZATO R, Kawabe K, Yamada D, Ikeno S, et al
    Disruption of Bmal1 Impairs Blood-Brain Barrier Integrity via Pericyte Dysfunction.
    J Neurosci. 2017;37:10052-10062.
    PubMed     Text format     Abstract available

  18. PARENT MJ, Zimmer ER, Shin M, Kang MS, et al
    Multimodal imaging in rat model recapitulates Alzheimer's Disease biomarkers abnormalities.
    J Neurosci. 2017 Nov 2. pii: 1346-17. doi: 10.1523/JNEUROSCI.1346-17.2017.
    PubMed     Text format     Abstract available


    Lancet Neurol

  19. YASSINE HN
    Targeting prodromal Alzheimer's disease: too late for prevention?
    Lancet Neurol. 2017 Oct 30. pii: S1474-4422(17)30372.
    PubMed     Text format    

  20. SOININEN H, Solomon A, Visser PJ, Hendrix SB, et al
    24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial.
    Lancet Neurol. 2017 Oct 30. pii: S1474-4422(17)30332.
    PubMed     Text format     Abstract available


    Neurology

  21. GAUTHIER S, Ng KP, Pascoal TA, Mathotaarachchi S, et al
    Author response: Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease.
    Neurology. 2017;89:1931.
    PubMed     Text format    

  22. BRENOWITZ WD, Hubbard RA, Keene CD, Hawes SE, et al
    Mixed neuropathologies and associations with domain-specific cognitive decline.
    Neurology. 2017;89:1773-1781.
    PubMed     Text format     Abstract available

  23. LANDIN-ROMERO R, Kumfor F
    Letter re: Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease.
    Neurology. 2017;89:1931.
    PubMed     Text format    

  24. RISACHER SL, Anderson WH, Charil A, Castelluccio PF, et al
    Alzheimer disease brain atrophy subtypes are associated with cognition and rate of decline.
    Neurology. 2017 Oct 25. pii: 10.1212/WNL.0000000000004670.
    PubMed     Text format     Abstract available

  25. WESTON PSJ, Poole T, Ryan NS, Nair A, et al
    Serum neurofilament light in familial Alzheimer disease: A marker of early neurodegeneration.
    Neurology. 2017 Oct 25. pii: 10.1212/WNL.0000000000004667.
    PubMed     Text format     Abstract available

  26. FILIPPI M, Basaia S, Canu E, Imperiale F, et al
    Brain network connectivity differs in early-onset neurodegenerative dementia.
    Neurology. 2017;89:1764-1772.
    PubMed     Text format     Abstract available


    PLoS Genet

  27. FERNANDEZ MV, Kim JH, Budde JP, Black K, et al
    Analysis of neurodegenerative Mendelian genes in clinically diagnosed Alzheimer Disease.
    PLoS Genet. 2017;13:e1007045.
    PubMed     Text format     Abstract available


    PLoS One

  28. CHIU PY, Hsu MH, Wang CW, Tsai CT, et al
    Visual hallucinations in Alzheimer's disease is significantly associated with clinical diagnostic features of dementia with Lewy bodies.
    PLoS One. 2017;12:e0186886.
    PubMed     Text format     Abstract available

  29. MIHELCIC M, Simic G, Babic Leko M, Lavrac N, et al
    Using redescription mining to relate clinical and biological characteristics of cognitively impaired and Alzheimer's disease patients.
    PLoS One. 2017;12:e0187364.
    PubMed     Text format     Abstract available

  30. YAO X, Yan J, Ginda M, Borner K, et al
    Mapping longitudinal scientific progress, collaboration and impact of the Alzheimer's disease neuroimaging initiative.
    PLoS One. 2017;12:e0186095.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  31. ANDREW RJ, Fernandez CG, Stanley M, Jiang H, et al
    Lack of BACE1 S-palmitoylation reduces amyloid burden and mitigates memory deficits in transgenic mouse models of Alzheimer's disease.
    Proc Natl Acad Sci U S A. 2017 Oct 23. pii: 201708568.
    PubMed     Text format     Abstract available

  32. VOLMAR CH, Salah-Uddin H, Janczura KJ, Halley P, et al
    M344 promotes nonamyloidogenic amyloid precursor protein processing while normalizing Alzheimer's disease genes and improving memory.
    Proc Natl Acad Sci U S A. 2017;114:E9135-E9144.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: